𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line

✍ Scribed by Seiji Sawada; Hiroshi Mese; Akira Sasaki; Norie Yoshioka; Tomohiro Matsumura

Publisher
Springer
Year
2003
Tongue
English
Weight
384 KB
Volume
51
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Preconditioning chemotherapy with paclit
Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model
✍ Xiang Huang; Guichun Huang; Haizhu Song; Longbang Chen πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 718 KB

## Abstract Adoptive cell therapy involving the use of __ex vivo__ generated cytokine‐induced killer cells (CIKs) provides a promising approach to immunotherapy. However, the therapeutic activity of CIKs is limited by the immunosuppressive factors active in the host. It has become increasingly appa

Mutation of p53 in head and neck squamou
Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis
✍ Genevieve A. Andrews; Sichuan Xi; Rebecca G. Pomerantz; Charles J. Lin; William πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

## Abstract ## Background. The p53 protein, a well‐known tumor suppressor that functions primarily as a transcription factor, initiates cell cycle arrest and apoptosis after genotoxic stress. The antiapoptotic regulator Bcl‐2 is a downstream modulator of p53‐induced apoptosis. Loss of function of